
Experts who created the technology behind Covid tests at the height of the pandemic have joined forces with a US biotech firm to develop tests for other conditions such as diabetes and Lyme disease.
Formed by a group of research scientists at the University of Aberdeen, Vertebrate Antibodies Ltd (VAL) has secured investment with Innova Medical Group (IMG) to form a new holding company, EpitogenX.